Neuro Flashcards
Q: What is Wernicke’s (receptive) aphasia and its cause?
A: Wernicke’s aphasia is caused by a lesion of the superior temporal gyrus, typically supplied by the inferior division of the left MCA. It results in fluent speech that makes no sense, with word substitutions and neologisms, but impaired comprehension.
Q: What characterizes Broca’s (expressive) aphasia?
A: Broca’s aphasia is characterized by non-fluent, laboured, and halting speech with impaired repetition but normal comprehension. It is caused by a lesion of the inferior frontal gyrus, typically supplied by the superior division of the left MCA.
Q: What is conduction aphasia and what causes it?
A: Conduction aphasia is caused by a stroke affecting the arcuate fasciculus, the connection between Wernicke’s and Broca’s areas. It results in fluent speech with poor repetition, but normal comprehension and awareness of errors.
Q: Describe global aphasia.
A: Global aphasia results from a large lesion affecting Wernicke’s, Broca’s, and the arcuate fasciculus areas, leading to severe expressive and receptive aphasia. Patients may still be able to communicate using gestures.
Q: What is the key difference between dysarthria and aphasia?
A: Dysarthria refers to a motor speech disorder affecting the muscles used in speech, while aphasia is a language disorder affecting speech production, comprehension, or both due to brain lesions.
Q: What are 5-HT3 antagonists primarily used for?
A: They are antiemetics used mainly in the management of chemotherapy-related nausea.
Q: Where do 5-HT3 antagonists mainly act?
A: They mainly act in the chemoreceptor trigger zone area of the medulla oblongata.
Q: Name two examples of 5-HT3 antagonists.
A: Ondansetron and palonosetron.
Q: What is the main advantage of second-generation 5-HT3 antagonists like palonosetron?
A: They have a reduced effect on the QT interval.
Q: What is a common adverse effect of 5-HT3 antagonists?
A: Constipation.
Q: What is a significant adverse effect associated with 5-HT3 antagonists?
A: Prolonged QT interval.
Q: What type of ataxia is caused by cerebellar hemisphere lesions?
A: Cerebellar hemisphere lesions cause peripheral ataxia, also known as ‘finger-nose ataxia’.
Q: What type of ataxia is associated with cerebellar vermis lesions?
A: Cerebellar vermis lesions cause gait ataxia.
Q: What is the genetic cause of ataxia telangiectasia?
A: Ataxia telangiectasia is caused by a defect in the ATM gene, which encodes for DNA repair enzymes.
Q: How is ataxia telangiectasia inherited?
A: Ataxia telangiectasia is inherited in an autosomal recessive manner.
Q: When does ataxia telangiectasia typically present?
A: It typically presents in early childhood with abnormal movements.
Q: List the main features of ataxia telangiectasia.
A: The main features include cerebellar ataxia, telangiectasia (spider angiomas), IgA deficiency with recurrent chest infections, and a 10% risk of developing malignancy (such as lymphoma or leukemia), as well as non-lymphoid tumors.
Q: What immunodeficiency is associated with ataxia telangiectasia?
A: IgA deficiency, which results in recurrent chest infections.
Q: What is autonomic dysreflexia?
A: Autonomic dysreflexia is a clinical syndrome occurring in patients with a spinal cord injury at or above the T6 spinal level, characterized by extreme hypertension and other autonomic disturbances.
Q: What are common triggers for autonomic dysreflexia?
A: Common triggers include faecal impaction and urinary retention, though many other triggers have been reported.
Q: What physiological response occurs in autonomic dysreflexia?
A: Afferent signals trigger a sympathetic spinal reflex via thoracolumbar outflow, but the usual centrally mediated parasympathetic response is prevented by the cord lesion.
Q: What are the main features of autonomic dysreflexia?
A: The main features include extreme hypertension, flushing and sweating above the level of the cord lesion, and agitation.
Q: What are the severe consequences of untreated autonomic dysreflexia?
A: Untreated cases can lead to severe consequences such as haemorrhagic stroke due to extreme hypertension.
Q: What is the management of autonomic dysreflexia?
A: Management involves removal or control of the stimulus and treatment of any life-threatening hypertension and/or bradycardia.